List view / Grid view
The number of immuno-oncology active agents has seen a tremendous boost during the past three years. The 2019 global immuno-oncology pipeline consists of almost 3,900 agents, making immuno-oncology discovery very attractive.
A global general immunology guide delivering the fundamentals of innate and adaptive immunity, including the description of immune cell types and their associated signaling pathways
The landscape of cancer treatment has changed dramatically in the last seven years, beginning with the approval of Ipilmumab in 2011, the first immunotherapy drug. Efforts to unsheathe the tumour cells of their protective microenvironment and expose them to an active immune response have delivered several monoclonal antibodies (mAbs) that…
This new guide reviewing the material and methods with HTRF® Toolbox reagents is for you...
Cisbio Bioassays has developed a GPCR platform based on the company’s HTRF® technology to measure second messenger accumulation...
This technical note gives you critical insights into on how to run, optimise and validate this ERK assay on your own cellular materials...
This short, easy-to-read Application Note goes over the background and basics of ERK signaling in multiple GPCR models...
In this application note, learn how to reduce time and sample consumption while achieving highly reproducible results from your assays with HTRF technology...
